People · Operator
Named in public records as an officer, director or promoter · active 2007–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quanta Therapeutics, Inc. | — | Biotechnology | Series C | $120.8M | $698.7M | 2021 |
| Auspex Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $82.8M | $951.9M | 2007 |
| Tonix Pharmaceuticals Holding Corp. | — | Pharmaceuticals | Series A | $10.3M | $9.7M | 2012 |
Samuel Saks at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samuel Saks on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Grey | 1 | 10 |
| Ernest Mario | 1 | 9 |
| David Collier | 1 | 8 |
| Maha Katabi | 1 | 6 |
| David Moss | 1 | 5 |
| Arjun Goyal | 1 | 5 |
| Pratik Shah | 1 | 5 |
| Gregory Sullivan | 1 | 3 |
| John Rhodes | 1 | 3 |
| Maria Fardis | 1 | 3 |
| Stuart Davidson | 1 | 3 |
| R. Gary Gilmore | 1 | 2 |
| Donald Landry | 1 | 2 |
| Patrick Grace | 1 | 2 |
| Leland Gershell | 1 | 2 |
| Benjamin Selzer | 1 | 2 |
| Seth Lederman | 1 | 2 |
| Charles Mather | 1 | 2 |
| Rod A. Ferguson | 1 | 1 |
| Pratik A. Shah | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.